Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: preliminary results.

Zaniboni, A; Marpicati, P; Simoncini, E; Gorni, F; Ferrari, V; Raffaglio, E; Garattini, M P; Marini, G

Zaniboni, A; Marpicati, P; Simoncini, E; Gorni, F; Ferrari, V; Raffaglio, E; Garattini, M P; Marini, G.

Affiliation

Zaniboni A; IIIa Medicina, Fondazione Beretta, Spedali Civili, Brescia, Italia.

Anticancer Res ; 7(4B): 813-5, 1987.

Article in En | MEDLINE | ID: mdl-3479042

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Drug Evaluation; Epirubicin; Hematopoiesis/drug effects; Humans; Middle Aged; Neoplasm Metastasis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Anticancer Res Year: 1987 Document type: Article Affiliation country: Italy Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links